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1. Introduction
   In 1996, the discovery of taxol, an anticancer compound 
(originally isolated from the plant Taxus brevifolia) from 
an endophytic fungal species Pestalotiopsis microspora, 
highlighted endophytic fungi as an alternate source for drug 
discovery[1]. Following this discovery, many studies reported 
the enormous potential of natural products from endophytes 
which exhibited antimicrobial, antiviral, antiparasitic and 
antitumor properties[2]. Endophytic fungi are described 
as fungi which live within plant tissue with no evidence 
of symptoms to the host plant. Some of these endophytes 
provide protection to their host plant from tissue invading 
pathogens by producing compounds that are involved the 
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Objective: To study bioactivity and compounds produced by an endophytic Phoma sp. fungus 
isolated from the medicinal plant Cinnamomum mollissimum. 
Methods: Compounds produced by the fungus were extracted from fungal broth culture with 
ethyl acetate. This was followed by bioactivity profiling of the crude extract fractions obtained via 
high performance liquid chromatography. The fractions were tested for cytotoxicity to P388 murine 
leukemic cells and antimicrobial activity against bacteria and pathogenic fungi. Compounds 
purified from active fractions which showed antibacterial, antifungal and cytotoxic activities were 
identified using capillary nuclear magnetic resonance analysis, mass spectrometry and admission 
to AntiMarin database. 
Results: Three known compounds, namely 4-hydroxymellein, 4,8-dihydroxy-6-methoxy-3-
methyl-3,4-dihydro-1H-isochromen-1-one and 1-(2,6-dihydroxyphenyl) ethanone, were isolated 
from the fungus. The polyketide compound 4-hydroxymellein showed high inhibitory activity 
against P388 murine leukemic cells (94.6%) and the bacteria Bacillus subtilis (97.3%). Meanwhile, 
4,8-dihydroxy-6-methoxy-3-methyl-3,4-dihydro-1H-isochromen-1-one, a benzopyran 
compound, demonstrated moderate inhibitory activity against P388 murine leukemic cells (48.8%) 
and the fungus Aspergillus niger (56.1%). The second polyketide compound, 1 (2,6-dihydroxyphenyl) 
ethanone was inactive against the tested targets.
Conclusions: These findings demonstrate the potential of endophytes as producers of 
pharmacologically important compounds, including polyketides which are major secondary 
metabolites in fungi. 
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host plant’s defense mechanism[3-5]. The fungi have been 
shown to produce similar compounds as their host plant[6,7]. 
This provided the rationale to investigate the bioactivity 
of compounds produced by endophytes, especially those 
isolated from medicinal plants.
   Plants of Cinnamomum species (sp.) are known to posses 
antimicrobial activities and are widely applied in herbal 
therapy in treating colds, sinusitis, bronchitis and fungal 
infection[8,9]. A wide range of biological activities ranging 
from antiseptic, antitumor to antifungal were reported to be 
found in constituents and essential oils of Cinnamomum 
sp. plants[10-12]. In this research, an endophytic fungus 
isolated from Cinnamomum mollissimum (C. mollissimum) 
was studied. The fungal isolate CB 007 [water agar (WA)], 
a Phoma sp., was previously investigated, and found to 
produce 5-hydroxyramulosin, a compound that was active 
against Aspergillus niger (A. niger) (IC50 1.56 µg/mL) and 
cytotoxic against murine leukemia cells (IC50 2.10 µg/mL)[13]. 
In this study, we report the isolation and biological activity 
of other compounds produced by CB 007 (WA).
2. Materials and methods
2.1. Sampling of C. mollissimum
   Plant parts of C. mollissimum were obtained from 
Universiti Kebangsaan Malaysia Forest Reserve, in Bangi, 
Selangor, Malaysia. Several twig samples were sampled from 
a young tree approximately 1.3 m tall. Samples were stored 
at 4 °C until further processing. The plant specimen voucher 
(No. 955) was deposited in the herbarium of Universiti 
Kebangsaan Malaysia and identified by university’s botanist.
2.2. Isolation of endophytes
   Plant samples were processed according to methods 
described by Jayanthi et al. 2011[14] and incubated on potato 
dextrose agar and WA at 27 °C. Emergence of hyphal tips 
was periodically checked for 3-14 d. The individual hypal 
tips were removed and cultured on potato dextrose agar 
at 27 °C and culture purity was monitored regularly. One 
of the fungal isolates, CB 007 (WA) was selected for further 
experimentation, based on the preliminary screening 
results[13].
2.3. Fermentation and extraction of fungal metabolites
   The fungal isolate was cultured in 1 000 mL Erlenmeyer 
flask containing 200 mL of potato dextrose broth, shaken at 
140 r/min, 27 °C for 14 d. Mycelia were removed via filtration 
and the culture broth was extracted with an equal amount 
of ethyl acetate overnight. The filtrate was concentrated 
by removing the solvents under reduced pressure at 35-
40 °C with a rotary evaporator (Büchi, New Castle, USA). The 
concentrated crude extract was ensured to be dry and stored 
at 4 °C.
2.4. High performance liquid chromatography (HPLC) analysis 
   An aliquot of the crude extract (250 µg) was analyzed by 
reverse phase C18 HPLC using a gradient solvent system 
comprising acetonitrile and ultra-pure water as described 
in methods by Santiago et al. 2012[13]. HPLC was performed 
on a Dionex (Sunnyvale, USA) system equipped with an ISCO 
Foxy Jr. sample collector using a reversed-phase analytical 
column (Phenomenex Prodigy C18, 4.6 mm伊250 mm, 5 µm) 
with photodiode array and an Alltech evaporative light 
scattering detection (ELSD) (Grace, Deerfield, USA).
2.5. Bioactivity profiling-cytotoxicity assay
   Fractions from crude extract (88 fractions伊200 µL) 
were collected in a microtiter plate from HPLC analysis. 
Daughter plates were made by transferring 50 µL from the 
original microtiter plate to another plate for analysis of 
cytotoxicity against P388 murine leukemic cells. The solvent 
was evaporated prior to the assay by using a centrifugal 
evaporator. Medium used for the cytotoxicity assay was 
β-methoxyethoxymethyl, fetal calf serum (10%), penicillin 
(266 µg/mL), streptomycin (132 µg/mL), L-glutamine 
(0.002 mol/L), sodium bicarbonate (2.2 g/L), and 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (0.0074 
mol/L). The plate was incubated 36 °C for 3 d. To obtain the 
result, 20 µL of thiazolyl blue tetrazolium solution (3.8 mg/mL 
in phosphate buffered saline) was added to every well and 
the plate was incubated for 4 h at 36 °C. After incubation, 
hydrochloric acid in isopropanol (170 µL, 0.08 mol/L) was 
used to dissolve the formazon product. Cell viability was 
determined by measuring the absorbance of every well at 
540 nm. The absorbance of cell free control and the analyte 
free cell control was taken as 0% and 100% growth reference, 
respectively. Cisplatin was used as reference positive control 
in this experiment.
2.6. Bioactivity profiling-antimicrobial assay
   The assay was done according to methods described 
in Santiago et al. 2012[13]. A second microtiter plate 
containing fractions (88 fractions伊200 µL) was obtained 
from HPLC analysis and assayed directly after evaporating 
the solvent with a centrifugal evaporator. Each well was 
added with 10 µL of 5% v/v methanol in water and 50 µL 
growth media. Media used for antifungal assay was RPMI-
1640 and for antibacterial assay was Mueller Hinton broth. 
This was followed by addition of 40 µL of suspension of test 
organisms. The inoculum size of test organisms used was 
2.5伊103 CFU/mL for the pathogenic fungi A. niger and A. 
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fumigatus and 5伊105 CFU/mL for Bacillus subtilis (B. subtilis) 
bacteria. Plates were incubated at 27 °C, 48 h for A. niger 
and A. fumigatus; 37 °C, 24 h for B. subtilis. After incubation, 
an tetrazolium solution (20 µL, 5 mg/mL) was added to all 
wells and plates were further incubated (27 °C, 4 h). Then, 
100 µL of dimethyl sulfoxide was added into every well to 
dissolve the formazon product. Cell viability percentage was 
determined by measuring the absorbance of every well at 540 
nm and subtracting the absorbance of cell free control. The 
absorbance of cell free control (solvent solution+medium) and 
the analyte free cell control (solvent solution+test organisms 
in medium) was taken as 0% and 100% growth reference, 
respectively. Cell growth inhibition was calculated as 100%-
cell viability%. The antibiotic gentamycin and antifungal 
amphotericin B used as positive controls in this experiment. 
2.7. Isolation of compounds
   The crude extract was subjected to HPLC by injecting 
250 µg of extract onto a C18 column (250 mm伊4.6 mm, 5 µm, 
Phenomenex Luna) using the same gradient solvent system 
as before for HPLC analysis. The collection of the bioactive 
fractions was scaled up to 10 times, to collect the pure 
compounds.
2.8. Determination of compounds
   The pure compounds were subjected to nuclear magnetic 
resonance (NMR) and mass spectrometry experiments were 
for identification. The NMR experiments was recorded on 
a Varian INOVA 500 spectrometer (Varian, Palo Alto, USA) 
at 23 °C, operating at 500 MHz at 23 °C, using a capillary 
probe. High resolution electron impact mass spectra were 
obtained on a liquid chromatography time-time of flight 
mass spectrometer (Micromass, Greater Manchester, UK). 
Structural elucidation of compounds process was aided by 
access to AntiMarin database. 
3. Results
   In bioactivity profiling, HPLC fractions were assayed 
on a microtiter plate for cytotoxicity and antimicrobial 
activity. A line graph was plotted to quantitatively indicate 
the inhibitory activity of HPLC fractions. These fractions 
correspond directly to collection time over 40 min from 
fraction 1 being the first collected fraction to fraction 88 
the last collected fraction. Figure 1 is showing bioactivity 
profile for first 36 HPLC fractions obtained from CB 007 (WA). 
The remaining 46 fractions which eluted later (after fraction 
36) did not exhibit any biological activity; hence the results 
were not included in Figure 1. An active region shown on 
the graph was interpreted as where most of the biological 
activity was found. The active region for CB 007 (WA) extract 
was from fraction 28 to 34 in which it was observed inhibitory 
activities against P388 murine leukemic cells, B. subtilis and 
A. niger (Figure 1). Several few fractions which eluted earlier 
(fraction 3 to 13) indicated the potent antifungal activity 
against A. fumigatus. 
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Figure 2. HPLC chromatogram with ELSD and UV detection, of 250 µg fungal endophyte CB 007 (WA) extract, showing major chromatograph peaks present in 
the biologically active region consisting fraction 31, 32, 33 and 34 which correlated to collection time between 10 to 14 min.
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Figure 1. Bioactivity profile of HPLC fractions (fraction 1 to 36) from the 
fungal endophyte CB 007(WA) extract showing inhibition of P388 murine 
leukemic cells, B. subtilis, and A. niger in active region. 
An active region is interpreted as region with most bioactivity observed as 
indicated by the marked area in the graph.
   The bioactivity profiling led to identification of active 
region which directly corresponded to a specific time region 
between 10 to 14 min in the HPLC chromatogram (Figure 
2). Four major peaks were present in the chromatogram 
in this time frame and each fraction that correlated to the 
peaks were collected and purified. This led to isolation 
of 4-hydroxymellein (A), 4,8-dihydroxy-6-methoxy-3-
methyl-3,4-dihydro-1H-isochromen-1-one (B) and 1-(2,6-
dihydroxyphenyl) ethanone (C) as depicted in Figure 3. The 
compound A, B and C eluted after 11.5 (fraction 32), 12.4 
(fraction 33) and 13.2 (fraction 34) min, respectively (Figure 
2). The compound 5-hyroxyramulosin has been reported 
previously[13,15] eluted after 10.47 min (fraction 31). The 
spectral data for compounds A, B and C is as following: 
Figure 3.  Structure of 4-hydroxymellein (A), 4,8-dihydroxy-6-methoxy-3-
methyl-3,4-dihydro-1H-isochromen-1-one (B) and 1-(2,6-dihydroxyphenyl) 
ethanone (C).
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   4-Hydroxymellein (A): white solids; UV (MeOH) λmax 210, 
245, 314 nm. HRESIMS m/z 193.0685 [M+H]+. 1H and 13C NMR 
data were consistent to previously reported literature[16,17]; 
Formula C10H10O4. 
   4,8-Dihydroxy-6-methoxy-3-methyl-3,4-dihydro-1H-
isochromen-1-one (B): white solids; UV (MeOH) λmax 215, 266, 
301 nm. HRESIMS m/z 255.0744 [M+H]+. Natural compound for 
stock screening; Formula C11H12O5.
   1-(2,6-dihydroxyphenyl) ethanone (C): white solids; UV 
(MeOH) λmax 210, 243, 310 nm. HRESIMS m/z 142.0443 [M]. 1H 
and 13C NMR data were consistent to previously reported 
literature[18]; Formula C8H8O3.
   The biological activity of bioactive HPLC fractions from CB 
007 (WA) and compounds isolated from them is summarized 
in Table 1. Compound A has inhibitory activity against 
P388 murine leukemic cells and B. subtilis. Compound B 
was inhibiting P388 murine leukemic cells and A. niger. 
However, compound C was inactive in all tested assays. 
Table 1 
Biological activity and major compounds isolated from HPLC fractions of the 
fungal endophyte CB007 (WA) extract.
Fractions
Biological activity (% inhibition)
Isolated compound
P388 B. subtilis A. niger
32 94.6  97.3 a- A
33 48.8 - 56.1 B
34 - - - C
b
Positive control 92.6 97.0 96.6
ano activity observed; bPositive controls used in the assay; cisplatin for 
P388 murine leukemic cell testing, gentamycin for antibacterial testing and 
amphotericin B for antifungal testing.
4. Discussion
   Endophytes are known to produce pharmacologically active 
compounds. The strategy in this research was to explore 
endophytic fungi from a medicinal plant. Cinnamomum 
plants are widely utilized as natural remedies to cure many 
diseases because of their healing properties. In herbal 
therapeutics, essential oils from the leaf, inner bark and 
stems of the plant are used as remedies[10]. Biologically active 
compounds from endophytes of Cinnamomum sp. have been 
studied previously but there is no reported study to date on 
endophytes from C. mollissimum.
   The endophyte CB 007 (WA) showed encouraging 
antimicrobial and cytotoxic activity in a screening 
assay[13]. Therefore, the research was undertaken to 
identify the compounds that gave rise to the observed 
activity. Metabolites from the isolate were extracted and 
analysed. This eventually led to the isolation of three known 
compounds; 4-hydroxymellein, 4,8-dihydroxy-6-methoxy-
3-methyl-3,4-dihydro-1H-isochromen-1-one and 1-(2,6-
dihydroxyphenyl) ethanone.
   The compounds 4-hydroxymellein and 1-(2,6-
dihydroxyphenyl) ethanone are polyketides that are 
synthesized by the polyketide synthase pathways. 
4-hydroxymellein was first isolated from a fungus, 
Cercospora taiwanesis. Fungus belonging to this genus is 
known to be pathogenic to crops such as sugarbeets and 
soyabeans[16]. A recent research also reported the isolation of 
4-hydroxymellein from an endophytic fungus of Penicillium 
sp., which exhibited active anti-fungal activities[19]. 
Meanwhile, the compound 1-(2,6-dihydroxyphenyl) 
ethanone was firstly discovered from Daldinia concentrica, 
a fungus belonging to Ascomycota division[18]. No biological 
activities has been reported for this compound. Polyketides 
compounds such as the above mentioned compounds are 
results of condensation of activated primary metabolites 
(acetyl-CoA and malonyl-CoA) to form b-ketoacetyl 
polymers which are linked to the enzyme by thioester bonds. 
They are structurally and functionally related to fatty acid 
synthases[20] and are identified by a common biosynthetic 
origin of carbon atoms derived from small carboxylic 
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acids[21]. Polyketides are frequently found as fungal 
metabolites and they are an important class of compounds 
in natural product drug discovery due to their structural 
diversity. They possess remarkable biologically activity 
as antibiotic, antifungal, anticancer, antiparasitic, and 
immunosuppressant[22]. Examples of polyketides that have 
been commercialized include amphotericin B (antifungal), 
lovastatin (anti-cholesterol), rapamycin (immunosuppressant) 
and erythromycin B (antibiotic). As such, the two polyketides 
compounds A and C can be potentially developed into drug 
in medicine industry.
   Compounds of mellein derivatives have been reported 
to display antimicrobial and cytotoxic activity which 
is supported by the observation in this study [23]. 
4-hydroxymellein demonstrated inhibitory activity against 
B. subtilis and P388 murine leukemic cells (97.3% and 94.6% 
respectively) which has not been reported before. However, 
1-(2,6-dihydroxyphenyl) ethanone was inactive for the tested 
activity. Assays conducted in this research were limited to 
evaluate antibacterial, antifungal and leukemia cytotoxic 
activity. As such, other in vitro assays such as antitumor or 
anti-parasitic assays can be employed to fully examine the 
potential of 1-(2,6-dihydroxyphenyl) ethanone.
   The compound 4,8-dihydroxy-6-methoxy-3-methyl-
3,4-dihydro-1H-isochromen-1-one showed moderate 
inhibitory activity against P388 murine leukemic cells 
(48.8%) and A. niger (56.1%) and no other biological activities 
were reported for this particular compound found from the 
literature review. This compound belongs to the benzopyran 
group which is an organic compound that is produced by 
fusion of benzene ring to heterocyclic pyran ring. Since 
benzopyrans are associated with polyketide synthesis this 
compound may have arisen from the same carbon framework 
as 4-hydroxymellein and 1-(2,6-dihydroxyphenyl) ethanone 
via polyketide synthase action. Among natural products, 
benzopyrans were found to be the core ring structures of 
flavonoids, isoflavanoids and isocoumarins[24]. Benzopyran 
derivatives possess numerous pharmocological properties as 
diuretic, analgesic, myorelaxant, and hypoglycaemic[25-27]. 
Besides this, benzopyrans are potential intermediates in the 
synthesis of steroid analogs, or function as building blocks 
in the production of pterocarpans and isoflavones that have 
strong fungicidal activity[28]. Hence, the fungicidal activity 
of compound B observed in this study is attributed to its 
structural and functional similarities to pterocarpans and 
isoflavones.
   Although, this study reports three known compounds, new 
biological activities have been identified in these compounds. 
In addition, the activity of the compounds is specific for 
either bacteria or fungi alone unlike toxic compounds which 
destroy all cell types. Therefore, further studies are needed to 
exploit the full potential of these compounds as antifungal or 
antibacterial agent. We conclude that endophytic fungi from 
medicinal plants is a significant resource for drug discovery.
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Comments 
Background
   The present investigation demonstrates the bioactivity of 
the three known compounds isolated from Phoma sp. in C. 
mollissimum. This may lead to further research and explore 
on the potential of endopytic fungal (Phoma sp.) and their 
active compounds.
Research frontiers
   The author found three actives compounds from Phoma 
sp. in C. mollissimum and its biological activity. Phoma 
sp. extract contained 4-Hydroxymellein, 4,8-Dihydroxy-6-
methoxyl-3,4-dihydro-1H-isochromen-1-one and 1-(2,6-
dihydroxyphenyl) ethanone. These compounds exihibited 
inhibition against P388, B. subtilis and A. niger.
Related reports
   So far, many research have been done on the isolation of 
endophytic fungi from medicinal plants. The present work 
revealed on the three known compounds isolated from 
Phoma sp. with theirs bioactivity.
Innovations and breakthroughs
   Several studies were carried out on the isolation of 
endophytic fungi from C. mollissimum. In the present 
study, authors have worked on the isolation of three active 
compounds from Phoma sp. endophytic fungi.
  
Applications
   The present investigation demonstrates the bioactivity of 
the three known compounds isolated from Phoma sp. in C. 
mollissimum. This may lead to further research and explore 
on the potential of endopytic fungal (Phoma sp.) and their 
active compounds. 
Peer review
   This study has studied the bioactivity of three compounds 
Carolina Santiago et al./Asian Pac J Trop Biomed 2014; 4(8): 627-632632
isolated from Phoma sp. fungi. The findings are well 
represented which indicated endophytic fungi may have a 
significance meaning in the drug discover. 
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